Cellmid Ltd
ASX:CDY
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Cellmid Ltd
Cellmid Ltd
Capital Expenditures
Cellmid Ltd
Capital Expenditures Peer Comparison
BWX
BKL
MCP
S66
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cellmid Ltd
ASX:CDY
|
Capital Expenditures
-AU$22.5k
|
CAGR 3-Years
41%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-8%
|
|
|
BWX Ltd
ASX:BWX
|
Capital Expenditures
-AU$21.3m
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-89%
|
CAGR 10-Years
N/A
|
|
|
Blackmores Ltd
ASX:BKL
|
Capital Expenditures
-AU$11.4m
|
CAGR 3-Years
23%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
McPherson's Ltd
ASX:MCP
|
Capital Expenditures
-AU$1.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
21%
|
CAGR 10-Years
27%
|
|
|
Star Combo Pharma Ltd
ASX:S66
|
Capital Expenditures
-AU$1.3m
|
CAGR 3-Years
37%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
B
|
Biome Australia Ltd
ASX:BIO
|
Capital Expenditures
-AU$400.9k
|
CAGR 3-Years
-31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cellmid Ltd's Capital Expenditures?
Capital Expenditures
-22.5k
AUD
Based on the financial report for Jun 30, 2021, Cellmid Ltd's Capital Expenditures amounts to -22.5k AUD.
What is Cellmid Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-8%
The average annual Capital Expenditures growth rates for Cellmid Ltd have been 41% over the past three years , 6% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet
